Autoantibodies that stabilize U1snRNP are a significant component of human autoantibodies to snRNP and delay proteolysis of Sm antigens in vitro

Journal of Rheumatology

Volumn 31, Issue 12, 2004, Pages 2382-2389

  Satoh, Minoru ^a,c   Akaogi, Jun ^a   Kuroda, Yoshiki ^a   Nacionales, Dina C ^a   Yoshida, Hideo ^a   Yamasaki, Yoshioki ^a   Reeves, Westley H ^a,b  

^a Department of Medicine ^*  (United States)

^b Div of Rheumatol/Clin Immunol   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Anti Sm antibodies; Antinuclear antibodies; Autoantibodes; Lupus; snRNP

Indexed keywords

ANTIGEN; ANTIGEN SM; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; MAGNESIUM CHLORIDE; MONOCLONAL ANTIBODY; PROTEINASE; SMALL NUCLEAR RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

ANTIBODY TITER; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DISSOCIATION; HUMAN; IN VITRO STUDY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOPRECIPITATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PEPTIDE HYDROLASES; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; RIBONUCLEOPROTEINS, SMALL NUCLEAR; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 10044257804     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Eisenberg RA, Tan EM, Dixon FJ. Presence of anti-Sm reactivity in autoimmune mouse strains. J Exp Med 1978;147:582-7.
2. Craft J. Antibodies to snRNPs in systemic lupus erythematosus. Rheum Dis Clin North Am 1992;18:311-35.
3. Greidinger EL, Hoffman RW. The appearance of U1 RNP antibody specificities in sequential autoimmune human antisera follows a characteristic order that implicates the U1-70 kd and B'/B proteins as predominant U1 RNP immunogens. Arthritis Rheum 2001;44:368-75.
4. Satoh M, Langdon JJ, Hamilton KJ, et al. Distinctive immune response patterns of human and murine autoimmune sera to U1 small nuclear ribonucleoprotein C protein. J Clin Invest 1996;97:2619-26.
5. Habets WJ, Hoet MH, van Venrooij WJ. Epitope patterns of anti-RNP antibodies in rheumatic diseases. Evidence for an antigen-driven autoimmune response. Arthritis Rheum 1990;33:834-41.
6. Pettersson I, Wang G, Smith EI, et al. The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. Arthritis Rheum 1986;29:986-96.
7. Satoh M, Richards HB, Hamilton KJ, Reeves WH. Human anti-nuclear ribonucleoprotein antigen autoimmune sera contain a novel subset of autoantibodies that stabilizes the molecular interaction of U1RNP-C protein with the Sm core particle. J Immunol 1997;158:5017-25.
8. Fatenejad S, Mamula M, Craft J. Role of intermolecular/intrastructural B and T-cell determinants in the diversification of autoantibodies to ribonucleoprotein particles. Proc Natl Acad Sci USA 1993;90:12010-4.
9. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
10. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (scleroderma). Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
11. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
12. Kasukawa R, Tojo T, Miyawaki S. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC, editors. Mixed connective tissue disease and antinuclear antibodies. Amsterdam: Excerpta Medica; 1987:41-7.
13. Billings PB, Allen RW, Jensen FC, Hoch SO. Anti-RNP monoclonal antibodies derived from a mouse strain with lupus-like autoimmunity. J Immunol 1982;128:1176-80.
14. Lerner EA, Lerner MR, Janeway CA Jr, Steitz JA. Monoclonal antibodies to nucleic acid-containing cellular constituents: probes for molecular biology and autoimmune disease. Proc Natl Acad Sci USA 1981;78:2737-41.
15. Pisetsky DS, Hoch SO, Klatt CL, O'Donnell MA, Keene JD. Specificity and idiotypic analysis of a monoclonal anti-Sm antibody with anti-DNA activity. J Immunol 1985;135:4080-5.
16. Stojanov L, Satoh M, Hirakata M, Reeves WH. Correlation of anti-synthetase antibody levels with disease course in a patient with interstitial lung disease and elevated muscle enzymes: Quantitation of anti-glycyl tRNA synthetase antibodies by immunoprecipitation. J Clin Rheumatol 1996;2:89-94.
17. Brahms H, Raker VA, van Venrooij WJ, Luhrmann R. A major, novel systemic lupus erythematosus autoantibody class recognizes the E, F, and G Sm snRNP proteins as an E-F-G complex but not in their denatured states. Arthritis Rheum 1997;40:672-82.
18. Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med 1994;180:2341-6.
19. Dong X, Hamilton KJ, Satoh M, Wang J, Reeves WH. Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen. J Exp Med 1994;179:1243-52.
20. Davidson HW, Watts C. Epitope-directed processing of specific antigen by B lymphocytes. J Cell Biol 1989;109:85-92.
21. Watts C, Lanzavecchia A. Suppressive effect of antibody on processing of T cell epitopes. J Exp Med 1993;178:1459-63.
22. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med 1995;181:1957-63.
23. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease - An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972;52:148-59.
24. Sharp GC, Irvin WS, May CM, et al. Association of autoantibodies to ribonucleoprotein and Sm antigens with mixed connective tissue disease, systemic lupus erythematosus and other rheumatic diseases. N Engl J Med 1976;295:1149-54.
25. Hermann H, Fabrizio P, Raker VA, et al. snRNP Sm proteins share two evolutionarily conserved sequence motifs which are involved in Sm protein-protein interaction. EMBO J 1995;14:2076-88.
26. Talken BL, Schafermeyer KR, Bailey CW, Lee DR, Huffman RW. T cell epitope mapping of the Smith antigen reveals that highly conserved Smith antigen motifs are the dominant target of T cell immunity in systemic lupus erythematosus. J Immunol 2001;167:562-8.
27. Satoh M, Yamagata H, Watanabe F, et al. Development of anti-Sm and anti-DNA antibodies followed by clinical manifestation of systemic lupus erythematosus in a patient with long-standing Sjogren's syndrome. Lupus 1995;4:63-5.
28. Fisher DE, Reeves WH, Wisniewolski R, Lahita RG, Chiorazzi N. Temporal shifts from Sm to ribonucleoprotein reactivity in systemic lupus erythematosus. Arthritis Rheum 1985;28:1348-55.
29. Field M, Melsom RD, Brennan FM, et al. Rapid clearance of the lupus antigen Sm is delayed by autoantibody: a possible mechanism of autoimmunity perpetuation. Clin Exp Immunol 1989;78:460-4.
30. Stocks MR, Williams DG, Maini RN. Differential induction of lupus associated antinuclear antibodies in MRL mice by monoclonal anti-Sm antibodies. Clin Exp Immunol 1987;67:492-9.
31. Stocks MR, Williams DG, Maini RN. Analysis of a positive feedback mechanism in the anti-Sm autoantibody response of MRL/MpJ-lpr/lpr mice. Eur J Immunol 1991;21:267-72.
32. Eisenberg RA, Pisetsky DS, Craven SY, Grudier JP, O'Donnell MA, Cohen PL. Regulation of the anti-Sm autoantibody response in systemic lupus erythematosus mice by monoclonal anti-Sm antibodies. J Clin Invest 1990;85:86-92.
33. Hardin JA. The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 1986;29:457-60.
34. James JA, Gross T, Scofield RH, Harley JB. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 1995;181:453-61.
35. Takeda Y, Wise KS, Wang G, et al. Human autoantibodies recognizing a native, macromolecular structure composed of Sm core proteins in U small nuclear RNP particles. Arthritis Rheum 1998;41:2059-67.
36. Buyon JP, Slade SG, Reveille JD, Hamel JC, Chan EK. Autoantibody responses to the "native" 52-kJDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren's syndrome. J Immunol 1994;152:3675-8.